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Seminal Vesicle Adherent to Rectal Wall Following 
Neoadjuvant Chemoradiotherapy: A Potential
False-Positive Diagnostic Pitfall.
Samia Liaquat, MD , Michael O. Idowu, MD, and Bryce S. Hatfield, MD
Abstract:
The standard of care for stage T3 and stage T4 
rectal adenocarcinomas involves neoadjuvant 
chemoradiotherapy followed by either low anterior 
resection or abdominopelvic resection. The 
presence of residual adenocarcinoma or
positive surgical margins provides useful prognostic 
information and can influence ongoing adjuvant 
therapy. Although uncommon, mimics of treated 
adenocarcinoma may be present in the surgical 
specimen. A high index of suspicion is
critical in avoiding potential false-positive pitfall, and 
the exclusion of mimics of treated adenocarcinoma 
is paramount to accurate diagnosis and treatment. 
Seminal vesicle epithelium has long been a 
challenge in differentiating prostatic 
adenocarcinoma from benign epithelium. However, 
the role of incidental seminal vesiculectomy in rectal 
resections due to fibrous adhesion to rectal wall 
secondary to chemoradiation has not been studied. 
As the seminal vesicle epithelium can show 
markedly atypical nuclei with radiation-type effect at 
baseline, the potential risk of misinterpretation as 
residual adenocarcinoma is high. In this article, we 
present 2 case reports of rectal adenocarcinoma 
treated with neoadjuvant chemoradiotherapy
followed by transabdominal resection (low anterior 
resection or abdominopelvic resection) with
incidental seminal vesiculectomies mimicking either 
residual adenocarcinoma or residual 
adenocarcinoma at a margin of resection.
Case #1
The first patient is a 63-year-old male with a history of prior LAR 
at an outside hospital for rectal adenocarcinoma reportedly 
involving the rectosigmoid junction and invading into, but not 
through, the muscularis propria (pT2) the previous year. A total of 
12 lymph nodes were resected and reported as negative (pN0), 
and all surgical margins were negative for carcinoma. Testing for 
mismatch repair proteins showed intact expression for MLH1, 
MSH2, MSH6,and PMS2. The patient did not receive 
neoadjuvant or adjuvant CRT as a result of this initial diagnosis, 
which is in keeping with the National Comprehensive Cancer 
Network guidelines for pT2 rectal carcinoma. Eleven months 
later, the patient presented with a 2-cm mass at the anastomotic 
site on surveillance colonoscopy. A biopsy of the mass 
demonstrated recurrent adenocarcinoma, and the patient was 
referred to our institution for surgical resection. Clinical restaging 
showed no evidence of metastatic disease, and the patient was 
treated with 6 weeks of preoperative 5-fluorouracil–based CRT to 
a total dose of 50.4 Gy, followed by an APR. Grossly, no residual 
tumor was identified. On microscopic examination, only a small 
focus of atypical glandular tissue was noted in the wall of the 
rectum (Figure 1A, arrow). Microscopic examination at higher 
power revealed irregular, braching, cleftlike glandular lumina
outside the muscularis propria. The glandular cells contained 
atypical cells with dark nuclei and occasional intranuclear
inclusions, and scant golden-brown pigment, surrounded by 
fibromuscular stroma (Figure 1B). Significant cautery artifact was 
present. On immunohistochemistry, the atypical glandular 
epithelium was negative for CDX2 (Figure 1C) and CK20 (Figure 
1D), and positive for CD10 (Figure 1E) and p63 (Figure 1F). 
Overall, the morphologic and Immunohistochemical features 
were consistent with seminal vesicle epithelium rather than 
residual adenocarcinoma.
Case #2 
The second case is a 60-year-old male who presented with 
rectal bleeding and an elevated CEA of 32.6 ng/mL. A diagnostic
colonoscopy revealed a 3 cm circumferential, ulcerated rectal 
mass 4 cm from anal verge. A biopsy showed moderately 
differentiated rectal adenocarcinoma. Clinical staging did not 
reveal any evidence of metastatic disease. On magnetic 
resonance imaging, the rectal mass penetrated <5 mm beyond 
the muscularis propria with no definite solid organ invasion and 
an intact peritoneal reflection. The patient underwent 
neoadjuvant CRT and LAR. Grossly, a full-thickness ulcerated 
lesion measuring 1.3 × 0.6 × 0.5 cm was noted in the rectum. 
Microscopically, residual adenocarcinoma was present invading 
the muscularis propria. One anastomotic donut contained a 
separate focus of glandular tissue with irregular lumina, 
pleomorphic nuclei, prominent nucleoli, and yellow cytoplasmic 
pigmentation/lipofuscin surrounded by a fibromuscular stroma 
(Figure 2A and B). The morphology was compatible with seminal 
vesicle tissue, and the margins were reported as negative.
Conclusion
Although the incidence of incidental seminal 
vesiculectomy in rectal adenocarcinoma excisions 
treated with CRT is unknown, one should be aware 
of the possibility in order to discern it from residual 
tumor. Misdiagnosis of seminal
vesicle epithelium in case #1 as adenocarcinoma 
could have led to the interpretation as partial 
response as opposed to pathologic complete 
response (ypT4a), potentially altering the patient’s 
adjuvant therapy. Similarly, in case #2,
diagnosis of seminal vesicle as residual 
adenocarcinoma at the anastomotic site may have 
led to misguided subsequent surgical re-excision of 
the margin or additional treatment. In order not to 
misinterpret seminal vesicle epithelium as
residual adenocarcinoma, careful attention to 
histologic features is paramount. Seminal vesicle 
epithelium can often be identified using 
histomorphologic features alone. In equivocal 
cases, staining for CDX2 and PAX8 can aid in
differentiation. 
Figure 1. (A) Seminal vesicle attached to the wall of the rectum 
(arrow; hematoxylin-eosin [H&E], 20×). (B) High-power view 
showing the seminal vesicle glandular epithelium with enlarged, 
hyperchromatic nuclei and adjacent fibromuscular stroma (H&E, 
400×). There was no staining for (C) CDX2 (CDX2, 400×) or (D) 
CK20 (CK20, 400×). The seminal vesicle epithelium showed 
positive staining for (E) CD10 (CD10, 400×) and (F) p63 (p63; 
400×).
Figure 2. The second case contained a portion of seminal vesicle 
in the anastomotic donut. (A) At low-power view 
(hematoxylineosin [H&E], 40×), the seminal vesicle epithelium 
and surrounding fibromuscular stroma is evident. (B) High-power 
magnification (H&E, 400×) demonstrates well-formed glands with 
cytoplasmic golden-brown pigment. The nuclei are large and 
irregular with prominent nucleoli.
